Skip to main content
. 2024 Aug 20;25(8):294. doi: 10.31083/j.rcm2508294

Table 1.

Baseline characteristics of patients with major and non-major adverse cardiovascular events.

Variables MACE group (n = 166) Non-MACE group (n = 376) p value
Age (year) 64.13 ± 14.42 59.73 ± 13.29 <0.001
Male [n (%)] 130 (78.3%) 305 (81.1%) 0.450
Smoking [n (%)] 86 (51.8%) 215 (57.2%) 0.246
Hypertension [n (%)] 104 (62.7%) 206 (54.8%) 0.088
Diabetes [n (%)] 48 (28.9%) 95 (25.3%) 0.374
SP (mmHg) 124.92 ± 26.54 128.28 ± 23.00 0.136
DP (mmHg) 75.03 ± 16.01 78.12 ± 15.70 0.036
HR 81.13 ± 22.02 77.43 ± 15.04 0.023
Neutrophil (×109/L) 8.48 (6.14, 11.28) 6.64 (4.93, 8.79) <0.001
Lymphocyte (×109/L) 1.30 (0.98, 1.84) 1.52 (1.08, 2.14) 0.013
Monocyte (×109/L) 0.60 (0.42, 0.88) 0.50 (0.39, 0.70) <0.001
Platelet (×109/L) 195.00 (157.00, 241.25) 196.00 (153.25, 236.00) 0.421
LnPIV 6.60 ± 0.98 5.95 ± 0.84 <0.001
LnSII 7.09 ± 0.80 6.69 ± 0.73 <0.001
LnPLR 4.97 ± 0.55 4.82 ± 0.51 0.002
LnNLR 1.82 ± 0.76 1.45 ± 0.70 <0.001
BUN (mmol/L) 6.35 (4.91, 8.06) 5.30 (4.33, 6.39) <0.001
Creatinine (μmol/L) 76.00 (61.95, 99.08) 70.80 (58.50, 79.25) <0.001
eGFR (mL/(min × 1.73 m2)) 90.49 (66.66, 101.13) 97.53 (83.62, 106.78) <0.001
UA (mmol/L) 361.46 (305.00, 433.10) 347.80 (289.05, 405.85) 0.027
TP (g/L) 62.95 (59.60, 66.10) 62.85 (59.73, 66.58) 0.709
TG (mmol/L) 1.43 (0.95, 2.05) 1.52 (1.08, 2.27) 0.053
TC (mmol/L) 4.16 (3.55, 4.82) 4.41 (3.80, 5.11) 0.008
Gensini Score 70.00 (44.00, 93.00) 62.00 (42.00, 84.00) 0.021
LVEF 58.90 (52.00, 62.00) 59.00 (56.00, 63.75) 0.005
LVFS 30.40 (28.00, 32.00) 30.40 (29.00, 33.00) 0.020
Killip Class 2–4 [n (%)] 80 (48.2%) 78 (20.7%) <0.001

Continuous variables are expressed as the mean ± SD, and categorical variables are expressed as percentages. The PIV, SII, PLR, and NLR are skewed data, and natural logarithmic transformations are normally distributed data.

SP, systolic blood pressure; DP, diastolic blood pressure; HR, heart rate; SD, standard deviation; MACE, major adverse cardiovascular event; LnPIV, natural logarithmic transformation of pan-immune-inflammation values; LnSII, natural logarithmic transformation of systemic immune-inflammation index; LnPLR, natural logarithmic transformation of platelet-to-lymphocyte ratio; LnNLR, natural logarithmic transformation of neutrophil-to-lymphocyte ratio; BUN, blood urea nitrogen; eGFR, glomerular filtration rate; UA, uric acid; TP, total protein; TG, triglyceride; TC, cholesterol; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening.